Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Auxilium Pharmaceuticals, Inc. : RDInvesting Provides Investors with Free In-Depth Equity Reports on AUXL, ENV, GLUU and ZMH

10/24/2013 | 09:05am US/Eastern

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) shares increased 4.45 percent to close at $17.12 a share Tuesday. The stock traded between $16.51 and $17.12 on volume of 832,089 shares traded. Analysts at JMP Securities have recently initiated coverage on the company with an "outperform" rating and a price target of $24.00. Shares of Auxilium Pharmaceuticals have fallen approximately 8.0 percent year-to-date.

Find out more about Auxilium Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/AUXL

Envestnet Inc. (NYSE: ENV) shares increased 1.60 percent to close at $36.92 a share Tuesday. The stock traded between $36.40 and $37.31 on volume of 248,852 shares traded. Analysts at Barrington have recently initiated coverage on the company with an "outperform" rating and a price target of $45.00. Shares of Envestnet have gained approximately 165.0 percent year-to-date.

Find out more about Envestnet including full access to the free equity report at:
www.RDInvesting.com/ENV

Glu Mobile Inc. (NASDAQ: GLUU) shares increased 0.59 percent to close at $3.25 a share Tuesday. The stock traded between $3.22 and $3.38 on volume of 4.16 million shares traded. Analysts at Cowen have recently initiated coverage on the company with an "outperform" rating and a price target of $5.00. Shares of Glu Mobile have gained approximately 42.0 percent year-to-date.

Find out more about Glu Mobile including full access to the free equity report at:
www.RDInvesting.com/GLUU

Zimmer Holdings, Inc. (NYSE: ZMH) shares gained 0.45 percent to close at $88.72 a share Tuesday. The stock traded between $87.81 and $89.31 on volume of 1.19 million shares traded. Analysts at Credit Suisse have recently upgraded the company?s rating to "outperform" from "neutral". Shares of Zimmer Holdings have gained approximately 33.0 percent year-to-date.

Find out more about Zimmer Holdings including full access to the free equity report at:
www.RDInvesting.com/ZMH

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com


© Accesswire 2013
Latest news on AUXILIUM PHARMACEUTICALS,
31m ago AUXILIUM PHARMACEUTICALS : NASDAQ:AUXL) Investor Alert: Investigation of Takeove..
1d ago AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Launches An Investiga..
1d ago AUXILIUM PHARMACEUTICALS : Pharmaceutical to be Taken Over by Irish Endo Interna..
3d ago AUXILIUM PHARMACEUTICALS : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the In..
6d ago AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Launches An Investiga..
6d ago AUXILIUM PHARMACEUTICALS : Ryan & Maniskas, LLP : Announces Investigation of Aux..
7d ago AUXILIUM PHARMACEUTICALS : INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUI..
7d ago AUXILIUM PHARMACEUTICALS : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the In..
7d ago AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Investigates..
10/10 AUXILIUM PHARMACEUTICALS : Endo lands $2.6bn deal for Auxilium
Advertisement
Chart
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF